Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Nature Immunology|February 4, 2022
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesVictoria G Hall, Victor H Ferreira, Heidi Wood, et al.
Molecular and Cellular Biology|June 6, 2018
Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB PathwayMariafausta Fischietti, Ahmet D Arslan, Antonella Sassano, et al.
The Journal of Biological Chemistry|October 28, 2003
Role of p38alpha Map kinase in Type I interferon signalingYongzhong Li, Antonella Sassano, Beata Majchrzak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Activation of protein kinase C delta by IFN-gammaDilip K Deb, Antonella Sassano, Fatima Lekmine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signalingSurinder Kaur, Antonella Sassano, Ajith M Joseph, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 10, 2022
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccineDeepali Kumar, Queenie Hu, Reuben Samson, et al.
The Journal of Biological Chemistry|July 14, 2009
Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responsesEfstratios Katsoulidis, Nathalie Carayol, Jennifer Woodard, et al.
Experimental Hematology|April 27, 2005
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cellsSurinder Kaur, Simrit Parmar, Jessica Smith, et al.
The Journal of Biological Chemistry|April 2, 2004
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cellsSimrit Parmar, Efstratios Katsoulidis, Amit Verma, et al.
Blood|March 26, 2005
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cellsSimrit Parmar, Jessica Smith, Antonella Sassano, et al.
Pageof 5